Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Background and study aims The National Institute for Health and Clinical Excellence (NICE) recommends screening high-risk groups for depression. Although there are good reasons for believing that people with a visual impairment are a high-risk group, screening for depression and referral for treatment is not currently part of the service that people receive at a low vision assessment. Therefore, this study aims to establish depression screening and referral for treatment at several optometrists practices across south-east Wales and at St Thomas’s Hospital in London. We aim to estimate the prevalence of depressive symptoms in people with a visual impairment and to compare two types of treatment. Who can participate? All patients aged 18 and over who attend these optometrists practices during the recruitment period will be asked to complete a depression screening questionnaire and will be asked to take part if they meet certain criteria for the study. What does the study involve? Participants are randomly allocated to one of three groups. For one group a letter is sent to the patient’s GP informing them that their patient may have a depressive disorder and inviting them to offer the patient assessment and treatment. The second group receive Problem Solving Treatment (PST). This involves a trained psychological therapist working with the patient in their own home or at one of the research centres. The third group are put on a waiting list and referred to their GP after the end of the study (6 months). All participants attend a follow-up appointment with their optician after 6 weeks, and complete a telephone interview before treatment, and 3 and 6 months later. What are the possible benefits and risks of participating? There are no known risks to taking part, but some of the interview questions may be emotionally uncomfortable. Where is the study run from? Cardiff University (UK). When is study starting and how long is it expected to run for? November 2011 to April 2014. Who is funding the study? Guide Dogs for the Blind (UK). Who is the main contact? Claire Bartlett (née Nollett) [email protected]
Critère d'inclusion
- Visual Impairment and depression